Related Experiment Video
Updated: Jun 12, 2026

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
Published on: June 28, 2019
Advances in eicosanoid research, novel therapeutic implications
Jesper Z Haeggström1, Agnes Rinaldo-Matthis, Craig E Wheelock
1Department of Medical Biochemistry and Biophysics, Division of Chemistry 2, Karolinska Institutet, S-17177 Stockholm, Sweden. jesper.haeggstrom@ki.se
Eicosanoids, crucial lipid mediators derived from arachidonic acid, are vital for cellular health and disease. This review highlights recent advances in eicosanoid structure and receptor biology, offering significant clinical insights.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Eicosanoids are oxygenated arachidonic acid metabolites.
- They include prostaglandins, thromboxanes, leukotrienes, and lipoxins.
- These lipid mediators are essential for cellular homeostasis and disease processes.
Purpose of the Study:
- To review recent advances in eicosanoid research.
- To highlight key discoveries and achievements in the field.
- To emphasize the structure and receptor biology of eicosanoids.
Main Methods:
- Literature review of recent publications.
- Focus on studies detailing eicosanoid structure.
- Analysis of research on eicosanoid receptor interactions.
Main Results:
- Recent progress in understanding eicosanoid structure-activity relationships.
- New insights into the diverse roles of eicosanoids in physiological and pathological conditions.
- Advances in identifying and characterizing eicosanoid receptors and their signaling pathways.
Conclusions:
- Eicosanoid structure and receptor biology are critical areas of research.
- Understanding these aspects has significant pharmacological and clinical implications.
- Continued investigation promises further therapeutic advancements.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
